col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: Journal of Hepatology
  original article Date Title Authors   All Authors
1 [GO] 2021―Nov―25 Prono-SARS: Prognosis of French COVID-19 Patients in 2020-2021 François Depret, Samir Bouam, Michaël Schwarzinger, Vincent Mallet
2 [GO] 2021―Nov―20 Assessing causal relationships between COVID-19 and non-alcoholic fatty liver disease Dong Liu, Qianlong Zhang, Pinqing Bai, Jian Zhao
3 [GO] 2021―Oct―14 Global impact of the first wave of COVID-19 on liver transplant centers: A multi-society survey (EASL-ESOT/ELITA-ILTS) Francesco Paolo Russo, Manhal Izzy, Ashwin Rammohan, Varvara A. Kirchner, Tommaso Di Maira, Luca Saverio Belli, et al. (+3)
4 [GO] 2021―Oct―09 Effectiveness of SARS-Cov-2 vaccination in liver transplanted patients: time for comprehensive data analysis Liane Rabinowich, Oren Shibolet, Helena Katchman
5 [GO] 2021―Oct―02 Reply Prognosis of Covid-19 patients with chronic liver disease in France in 2020 Vincent Mallet, Michaël Schwarzinger, Vincent Mallet, Michaël Schwarzinger, Nathanaël Beeker, Samir Bouam, et al. (+6)
6 [GO] 2021―Sep―30 Focus on the decisions to forego life-sustaining therapies during ICU stay of patients with cirrhosis and COVID-19: a case control study from the prospective COVID-ICU database Mikhael Giabicani, Alice Le Menestrel, Olivier Roux, Pierre-Emmanuel Rautou, Emmanuel Weiss
7 [GO] 2021―Aug―26 Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases Paul J. Thuluvath, Polly Robarts, Mahak Chauhan
8 [GO] 2021―Aug―25 New-Onset Autoimmune Hepatitis following mRNA Covid-19 Vaccination in a 36-year-old woman with Primary Sclerosing Cholangitis - should we be more vigilant? Taotao Zhou, Florian Fronhoffs, Leona Dold, Christian P. Strassburg, Tobias J. Weismüller
9 [GO] 2021―Aug―24 Impact of the COVID-19 pandemic on hepatitis C diagnosis in Brazil: Is the global hepatitis C elimination strategy at risk? Rodrigo Feliciano do Carmo, Carlos Dornels Freire de Souza
10 [GO] 2021―Aug―10 Autoimmune Hepatitis Developing After Coronavirus Disease 2019 (COVID-19) Vaccine: One or Even Several Swallows Do Not Make a Summer Bril Fernando
11 [GO] 2021―Aug―03 Effectiveness of SARS-Cov-2 vaccination in liver transplanted patients: the debate is open! Maria Guarino, Valentina Cossiga, Ilaria Esposito, Furno Alessandro, Filomena Morisco
12 [GO] 2021―Jul―31 Liver injury following SARS-CoV-2 vaccination: a multicenter case series Hersh Shroff, Sanjaya K. Satapathy, James M. Crawford, Nancy J. Todd, Lisa B. VanWagner
13 [GO] 2021―Jul―19 Association of chronic liver disease with the prognosis of COVID-19 patients Junyu Long, Xinting Sang, Haitao Zhao
14 [GO] 2021―Jul―17 SARS-CoV-2-specific immunity in immunosuppressed COVID-19 convalescents with autoimmune hepatitis Theresa Kirchner, Elmar Jaeckel, Christine S. Falk, Britta Eiz-Vesper, Richard Taubert
15 [GO] 2021―Jul―15 Unraveling the role of liver sinusoidal endothelial cells in COVID-19 liver injury Antonio Saviano, Thomas F. Baumert
16 [GO] 2021―Jul―10 AN ANUSUAL CASE OF ACUTE CHOLESTATIC HEPATITIS AFTER m-RNABNT162b2 (COMIRNATY) SARS-CoV-2 VACCINE: COINCIDENCE, AUTOIMMUNITY OR DRUG RELATED LIVER INJURY? Francesca Lodato, Anna Larocca, Antonietta D’Errico, Vincenzo Cennamo
17 [GO] 2021―Jul―08 The mRNA COVID-19 vaccine - a rare trigger of Autoimmune Hepatitis? Cathy McShane, Clifford Kiat, Jonathan Rigby, Órla Crosbie
18 [GO] 2021―Jun―24 Intravenous ketamine is a risk factor for jaundice in Covid-19 patients Vincent Mallet, Vincent Mallet, Kilian Bock, Mourad Dellagi, Marion Tano, Virginie Siorat, et al. (+30)
19 [GO] 2021―Jun―22 Comment to the letter of Bril F et al. “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?” Daniel Clayton-Chubb, Daniel Schneider, Elliot Freeman, William Kemp, Stuart K. Roberts
20 [GO] 2021―Jun―18 Autoimmune hepatitis following COVID-19 Vaccination: true causality or mere association? Chin Kimg Tan, Yu Jun Wong, Lai Mun Wang, Tiing Leong Ang, Rahul Kumar
21 [GO] 2021―Jun―17 Response to letter to the editor by Capecchi et al. “Comment to the letter of Bril F et al. “Autoimmune Hepatitis Developing After Coronavirus Disease 2019 (COVID-19) Vaccine: Causality or Casualty?” Fernando Bril, David M. Fettig
22 [GO] 2021―Jun―12 Another case of autoimmune hepatitis after SARS-CoV-2 vaccination. Still casualty? Maria-Carlota Londoño, Jordi Gratacós-Ginès, Joaquín Sáez-Peñataro
23 [GO] 2021―Jun―09 Autoimmune hepatitis following sars-cov-2 VACCINE: MAY not be a casualty Alba Rocco, Costantino Sgamato, Debora Compare, Gerardo Nardone
24 [GO] 2021―Jun―06 Reply to: Comments on "Association of liver abnormalities with in-hospital mortality in patients with COVID-19 Ze-yang Ding, Gan-xun Li, Chang Shu, Ping Yin, Bixiang Zhang
25 [GO] 2021―May―28 High acceptance rate of COVID-19 vaccination in liver transplant recipients Edoardo G. Giannini, Simona Marenco
26 [GO] 2021―May―25 Protected or not protected, that is the question - First data on COVID-19 vaccine responses in patients with NAFLD and liver transplant recipients Markus Cornberg, Christiane S. Eberhardt
27 [GO] 2021―May―14 Prognosis of French COVID-19 patients with chronic liver disease: a national retrospective cohort study for 2020 Vincent Mallet, Nathanael Beeker, Samir Bouam, Philippe Sogni, Stanislas Pol, Vincent Mallet, et al. (+9)
28 [GO] 2021―May―13 Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy Matthew J. McConnell, Nao Kawaguchi, Reiichiro Kondo, Aurelio Sonzogni, Lisa Licini, Clarissa Valle, et al. (+19)
29 [GO] 2021―May―07 HCV detection is possible during SARS CoV-2 testing; and throughout COVID-19 vaccination? Javier Crespo, Álvaro Díaz-González, Joaquín Cabezas
30 [GO] 2021―May―05 Comment to the letter of Bril F et al. “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) Vaccine: Causality or casualty?” Pier Leopoldo Capecchi, Pietro Enea Lazzerini, Stefano Brillanti
31 [GO] 2021―Apr―24 Risk stratification in hospitalized COVID-19 patients Angela Horvath, Theresa Lind, Natalie Frece, Herbert Wurzer, Vanessa Stadlbauer
32 [GO] 2021―Apr―24 Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): a multicenter study Jitao Wang, Zhiyun Hou, Jianxin Liu, Ye Gu, Yunhong Wu, Zhenhuai Chen, et al. (+39)
33 [GO] 2021―Apr―24 Letter regarding “association of liver abnormalities with in-hospital mortality in patients with COVID-19 Meng-Si Luo, Guan-Jiang Huang
34 [GO] 2021―Apr―21 Reply to: Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients Manuel Rodríguez-Perálvarez, Jordi Colmenero, Magdalena Salcedo
35 [GO] 2021―Apr―21 Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) Vaccine: Causality or casualty? Fernando Bril, Sameer Al Diffalha, Mark Dean, David M. Fettig
36 [GO] 2021―Apr―21 Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients Liane Rabinowich, Ayelet Grupper, Roni Baruch, Merav Ben-Yehoyada, Tami Halperin, Dan Turner, et al. (+6)
37 [GO] 2021―Apr―20 DECREASE IN VIRAL HEPATITIS DIAGNOSES DURING THE COVID-19 PANDEMIC IN THE NETHERLANDS Milan J. Sonneveld, Irene K. Veldhuijzen, Thijs van de Laar, Eline L.M. Op de Coul, Adriaan J. van der Meer
38 [GO] 2021―Mar―20 Liver Injury in COVID-19 - The culprit may not be COVID-19! Aditya Singh, Madhumita Premkumar, Virendra Singh
39 [GO] 2021―Mar―20 Progressive cholangiopathy in Covid-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered Pierre Deltenre, Christophe Moreno, Eric Trépo
40 [GO] 2021―Mar―20 Let’s leverage SARS-CoV2 vaccination to screen for hepatitis C screening in Spain, in Europe, around the world Javier Crespo, Jeffrey V. Lazarus, Paula Iruzubieta, Federico García, Javier García-Samaniego
41 [GO] 2021―Feb―21 Intravenous ketamine and progressive cholangiopathy in Covid-19 patients Vincent Mallet
42 [GO] 2021―Feb―21 PRIMARY BILIARY CHOLANGITIS ASSOCIATED WITH SARS-COV2 INFECTION Alessandra Bartoli, Stefano Gitto, Pamela Sighinolfi, Carmela Cursaro, Pietro Andreone
43 [GO] 2021―Feb―07 EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients Markus Cornberg, Maria Buti, Christiane S. Eberhardt, Paolo Antonio Grossi, Daniel Shouval
44 [GO] 2021―Feb―06 Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients. Gwilym J. Webb, Andrew M. Moon, Eleanor Barnes, A. Sidney Barritt, Thomas Marjot
45 [GO] 2021―Jan―26 SARS-CoV-2 infection in patients with autoimmune hepatitis Thomas Marjot, Gustav Buescher, Marcial Sebode, Eleanor Barnes, Alfred S. Barritt, Matthew J. Armstrong, et al. (+9)
46 [GO] 2021―Jan―13 Detecting HCV infection by means of mass population SARS-CoV-2 screening: a pilot experience in Northern Italy Andrea Giacomelli, Gabriele Pagani, Federico Conti, Cinzia Bassoli, Massimo Galli
47 [GO] 2020―Dec―20 Impact of the COVID 19 Pandemic on HCV Elimination in Spain Maria Buti, Raquel Domínguez-Hernández, Miguel Angel Casado
48 [GO] 2020―Dec―19 Association of liver abnormalities with in-hospital mortality in patients with COVID-19 Ze-yang Ding, Gan-xun Li, Lin Chen, Chang Shu, Jia Song, Wei Wang, et al. (+22)
49 [GO] 2020―Dec―16 Increased expression of key SARS-CoV-2 entry points in multiple tissues in individuals with NAFLD Abraham S. Meijnikman, Sjoerd Bruin, Albert K. Groen, Max Nieuwdorp, Hilde Herrema
50 [GO] 2020―Nov―20 NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression - The debate continues Kamran Mushtaq, Muhammad Umair Khan, Fatima Iqbal, Deema Hussam Alsoub, Hammad Shabir Chaudhry, Fateen Ata, et al. (+7)
51 [GO] 2020―Oct―30 Reply to: ‘NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression-The debate continues’ Dong Ji, Gregory Cheng, George Lau
52 [GO] 2020―Oct―20 Obese patients with NASH have increased hepatic expression of SARS-CoV-2 critical entry points Marcos F. Fondevila, Maria Mercado-Gómez, Amaia Rodríguez, Maria J. Gonzalez-Rellan, Paula Iruzubieta, Víctor Valentí, et al. (+8)
53 [GO] 2020―Oct―09 SARS-CoV-2 massive testing: a window of opportunity to catch up with HCV elimination Javier Crespo, Álvaro Díaz-González, Paula Iruzubieta, Susana Llerena, Joaquín Cabezas
54 [GO] 2020―Oct―08 COVID-19: discovery, diagnostics and drug development Tarik Asselah, David Durantel, Eric Pasmant, George Lau, Raymond F. Schinazi
55 [GO] 2020―Oct―06 Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study Thomas Marjot, Andrew M. Moon, Jonathan A. Cook, Sherief Abd-Elsalam, Costica Aloman, Matthew J. Armstrong, et al. (+24)
56 [GO] 2020―Sep―16 Dried blood spots are a useful tool for hepatitis A screening in the pandemic areas with medical resource-limited condition Chikako Yamamoto, Junko Tanaka, Vichit Ork, Shintaro Nagashima, Channarena Chuon, Ko Ko, et al. (+2)
57 [GO] 2020―Sep―10 Health status of patients with Autoimmune hepatitis is not affected by the SARS-CoV-2 outbreak in Flanders (Belgium) Xavier Verhelst, Nicky Somers, Anja Geerts, Helena Degroote, Hans Van Vlierberghe
58 [GO] 2020―Sep―02 Covid-19 can mimic acute cholecystitis and is associated with the presence of viral RNA in the gallbladder wall Alexandre Balaphas, Kyriaki Gkoufa, Jeremy Meyer, Andrea Peloso, Aurélie Bornand, Thomas A. McKee, et al. (+2)
59 [GO] 2020―Aug―07 Authors’ reply on HIGH RATES OF 30-DAY MORTALITY IN PATIENTS WITH CIRRHOSIS AND COVID-19 Massimo Iavarone, Roberta D’Ambrosio, Pietro Lampertico
60 [GO] 2020―Aug―07 Impact of COVID-19 on global hepatitis C elimination efforts Sarah Blach, Loreta A. Kondili, Alessio Aghemo, Zongzhen Cai, Ellen Dugan, Chris Estes, et al. (+8)
61 [GO] 2020―Aug―01 Epidemiological pattern, incidence and outcomes of COVID-19 in liver transplant patients. Jordi Colmenero, Manuel Rodríguez-Perálvarez, Magdalena Salcedo, Ana Arias-Milla, Alejandro Muñoz-Serrano, Javier Graus, et al. (+29)
62 [GO] 2020―Jul―27 Strengthening vaccine confidence during the COVID-19 pandemic: A new opportunity for global hepatitis B virus elimination Jeffrey V. Lazarus, Camila A. Picchio, Shevanthi Nayagam, Scott Ratzan, Mark Thursz
63 [GO] 2020―Jul―13 SARS-CoV2 in patients on antiviral HBV and HCV therapy in Spain Sabela Lens, Mireia Miquel, Beatriz Mateos-Muñoz, Javier García-Samaniego, Xavier Forns
64 [GO] 2020―Jul―06 Inflammasome Activation and Pyroptosis in Lymphopenic COVID-19 Liver Patients Alexander Kroemer, Khalid Khan, Matthew Plassmeyer, Oral Alpan, M.A. Haseeb, Raavi Gupta, Thomas M. Fishbein
65 [GO] 2020―Jul―04 Reply to “Liver tests abnormalities in COVID-19: trick or treat?” Qingxian Cai, Lin Xu, Jun Chen
66 [GO] 2020―Jun―23 Hepatocellular Type II Fibrinogen Inclusions in a Patient with Severe COVID-19 and Hepatitis Montserrat Fraga, Darius Moradpour, Florent Artru, Elodie Romailler, Jonathan Tschopp, Antoine Schneider, et al. (+5)
67 [GO] 2020―Jun―23 SARS-CoV-2 infection in liver-Author’s reply Yijin Wang, Fengmin Lu, Jingmin Zhao
68 [GO] 2020―Jun―20 Is the increased risk for MAFLD patients to develop severe COVID-19 linked to perturbation of the gut-liver axis? Gabriella Assante, Roger Williams, Neil Alexander Youngson
69 [GO] 2020―Jun―20 The impact of COVID-19 on the clinical outcome of patients with cirrhosis deserves more attention and research Feng Gao, Zhi-Ming Huang
70 [GO] 2020―Jun―20 Characteristics of pregnant COVID-19 patients with liver injury Guangtong Deng, Furong Zeng, Lijuan Zhang, Hui Chen, Xiang Chen, Mingzhu Yin
71 [GO] 2020―Jun―20 Letter regarding [High rates of 30-day mortality in patients with cirrhosis and COVID-19] Mohammed A. Medhat, Mohamed El Kassas
72 [GO] 2020―Jun―15 COVID-19 and Liver. Dinesh Jothimani, Radhika Venugopal, Mohammed Forhad Abedin, Ilankumaran Kaliamoorthy, Mohamed Rela
73 [GO] 2020―Jun―09 High rates of 30-day mortality in patients with cirrhosis and COVID-19 Massimo Iavarone, Roberta D’Ambrosio, Alessandro Soria, Michela Triolo, Nicola Pugliese, Paolo Del Poggio, et al. (+16)
74 [GO] 2020―Jun―02 SARS-CoV-2: is the liver merely a bystander to severe disease? Mansoor N. Bangash, Jaimin M. Patel, Dhruv Parekh, Nicholas Murphy, Rachel M. Brown, Ahmed M. Elsharkawy, et al. (+3)
75 [GO] 2020―May―28 Single cell RNA sequencing analysis did not predict hepatocyte infection by SARS-CoV-2 Vincent De Smet, Stefaan Verhulst, Leo A. van Grunsven
76 [GO] 2020―May―27 Liver tests abnormalities in COVID-19: trick or treat? Edoardo Vespa, Nicola Pugliese, Daniele Piovani, Antonio Capogreco, Silvio Danese, Alessio Aghemo
77 [GO] 2020―May―23 SARS-CoV-2 related liver impairment - perception may not be the reality Cyriac Abby Philips, Rizwan Ahamed, Philip Augustine
78 [GO] 2020―May―23 An international multicentre study of protocols for liver transplantation during a pandemic: A case for quadripartite equipoise Claire Alexandra Chew, Shridhar Ganpathi Iyer, Alfred Wei Chieh Kow, Krishnakumar Madhavan, Andrea Sze Teng Wong, Karim J. Halazun, et al. (+18)
79 [GO] 2020―May―22 A Local Response to COVID-19 for Advanced Liver Disease: Current Model of Care, Challenges and Opportunities Marina Serper, Abraham Shaked, Kim M. Olthoff, Maarouf Hoteit, Brenda Appolo, K. Rajender Reddy
80 [GO] 2020―May―21 High Mortality Rates for SARS-CoV-2 Infection in Patients with Pre-existing Chronic Liver Disease and Cirrhosis: Preliminary Results from an International Registry Andrew M. Moon, Gwilym J. Webb, Costica Aloman, Matthew J. Armstrong, Tamsin Cargill, Renumathy Dhanasekaran, et al. (+13)
81 [GO] 2020―May―20 Lack of genetic evidence that fatty liver disease predisposes to COVID-19 Luca Valenti, Oveis Jamialahmadi, Stefano Romeo
82 [GO] 2020―May―12 Health status of patients with Autoimmune Liver Disease during SARS-CoV-2 outbreak in northern Italy Angelo Di Giorgio, Emanuele Nicastro, Camilla Speziani, Massimo De Giorgio, Luisa Pasulo, Bianca Magro, et al. (+2)
83 [GO] 2020―May―11 SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19 Yijin Wang, Shuhong Liu, Hongyang Liu, Wei Li, Fang Lin, Lina Jiang, et al. (+16)
84 [GO] 2020―May―11 Reply to: ‘Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis’ Dong Ji, Enqiang Qin, George Lau
85 [GO] 2020―May―06 Reply to “Clinical characteristics of COVID-19 patients with abnormal liver tests” Qingxian Cai, Jun Chen
86 [GO] 2020―May―06 Reply to: ‘No evidence for an increased liver uptake of SARS-CoV-2 in metabolic associated fatty liver disease’ Dong Ji, Enqiang Qin, Jing Xu, Dawei Zhang, Gregory Cheng, Yudong Wang, George Lau
87 [GO] 2020―Apr―30 No evidence for an increased liver uptake of SARS-CoV-2 in metabolic associated fatty liver disease Louise Biquard, Dominique Valla, Pierre-Emmanuel Rautou
88 [GO] 2020―Apr―27 Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis Yu-Jie Zhou, Kenneth I. Zheng, Xiao-Bo Wang, Hua-Dong Yan, Qing-Feng Sun, Ke-Hua Pan, et al. (+5)
89 [GO] 2020―Apr―27 Clinical characteristics of COVID-19 patients with abnormal liver tests Peng Chen, Benhong Zhou
90 [GO] 2020―Apr―17 Multicenter analysis of clinical characteristics and outcome of COVID-19 patients with liver injury Xiaolong Qi, Chuan Liu, Zicheng Jiang, Ye Gu, Guo Zhang, Chuxiao Shao, et al. (+20)
91 [GO] 2020―Apr―14 COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care Elliot B. Tapper, Sumeet K. Asrani
92 [GO] 2020―Apr―14 Characteristics of Liver Tests in COVID-19 Patients Qingxian Cai, Deliang Huang, Hong Yu, Zhibin Zhu, Zhang Xia, Yinan Su, et al. (+10)
93 [GO] 2020―Apr―10 Highlights for management of patients with Autoimmune Liver Disease during COVID-19 pandemia Ana Lleo, Pietro Invernizzi, Ansgar W. Lohse, Alessio Aghemo, Marco Carbone
94 [GO] 2020―Apr―08 Implication of non-alcoholic fatty liver diseases (NAFLD) in patients with COVID-19: a preliminary analysis Dong Ji, Enqiang Qin, Jing Xu, Dawei Zhang, Gregory Cheng, Yudong Wang, George Lau


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.006 sec